Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models

[1] Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30

[2] Miller KD(2019)Breast cancer treatment: a review Jama. 321 288-300

[3] Jemal A(2008)Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer Am J Clin Pathol 130 879-882

[4] Waks AG(2012)Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 23 vii11-vvii9

[5] Winer EP(2010)Metastatic behavior of breast cancer subtypes J Clin Oncol 28 3271-3277

[6] Gomez-Fernandez C(2015)Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges Oncotarget. 6 33146-33164

[7] Daneshbod Y(2018)Progesterone receptor a promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen J Biol Chem 293 1163-1177

[8] Nassiri M(2001)Estrogen and the risk of breast cancer N Engl J Med 344 276-285

[9] Milikowski C(2012)ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer Trends Endocrinol Metab 23 73-82

[10] Alvarez C(2004)Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion Crit Rev Oncol Hematol 51 55-67

[1] Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30

[2] Miller KD(2019)Breast cancer treatment: a review Jama. 321 288-300

[3] Jemal A(2008)Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer Am J Clin Pathol 130 879-882

[4] Waks AG(2012)Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 23 vii11-vvii9

[5] Winer EP(2010)Metastatic behavior of breast cancer subtypes J Clin Oncol 28 3271-3277

[6] Gomez-Fernandez C(2015)Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges Oncotarget. 6 33146-33164

[7] Daneshbod Y(2018)Progesterone receptor a promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen J Biol Chem 293 1163-1177

[8] Nassiri M(2001)Estrogen and the risk of breast cancer N Engl J Med 344 276-285

[9] Milikowski C(2012)ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer Trends Endocrinol Metab 23 73-82

[10] Alvarez C(2004)Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion Crit Rev Oncol Hematol 51 55-67